Completed
This workshop examined how clinical practice guidelines can impact adoption of genomics into routine medical care and how guidelines for genomic testing are developed by various organizations and implemented within clinical practice, with a focus on exploring inconsistencies across guidelines.
Featured publication
Workshop_in_brief
·2025
Clinical practice guidelines are condition- or disease-specific recommendations for the appropriate health care management of patients. Because guidelines can differ between different organizations, the National Academies Roundtable on Genomics and Precision Health and National Cancer Policy Forum h...
View details
Description
A planning committee of the National Academies of Sciences, Engineering, and Medicine will organize and conduct a public workshop to examine how clinical practice guidelines can impact adoption of genomics into routine medical care. The workshop will examine how guidelines for genomic testing are developed by various organizations and implemented within clinical practice, with a focus on exploring inconsistencies across guidelines.
The workshop’s presentations and discussions may focus on:
- Exploring the processes and methodologies used by different professional societies, organizations, and collaborations to gather evidence and develop clinical guidelines for appropriate genomic testing.
- Understanding how clinicians, payers, test developers, laboratory partners, and others decide which guideline(s) to follow and how they use these guidelines in practice.
- Examining elements that are consistent and those that differ across clinical guidelines for genomics and how these areas impact patients (e.g., access, coverage, and equity in care), clinicians, payers, test developers, laboratories, and others.
- Discussing opportunities for a possible path forward for more compatible clinical guidelines for genomics to improve patient care.
The planning committee will organize the workshop, develop the agenda, select and invite speakers and discussants, and moderate or identify moderators for the discussions. A proceedings-in brief of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Committee
Co-Chair
Co-Chair
Member
Member
Member
Member
Member
Member
Member
Member
Member
Sponsors
23andMe
All of Us Research Program
American Academy of Nursing
American Association for Cancer Research
American Cancer Society
American College of Medical Genetics and Genomics
American College of Radiology
American Medical Association
American Society of Clinical Oncology
American Society of Human Genetics
Association for Molecular Pathology
Association of American Cancer Institutes
Association of Community Cancer Centers
Biogen
Blue Cross Blue Shield Association
Centers for Disease Control and Prevention (CDC)
College of American Pathologists
Flatiron Health
Geisinger Health
Genome Medical
Health Resources and Services Administration
Illumina Inc.
Kaiser Permanente
Merck
Myriad Genetics
National Cancer Institute
National Comprehensive Cancer Network
National Human Genome Research Institute
National Institute of Mental Health
National Institute of Nursing Research
National Institute on Aging
National Patient Advocate Foundation
National Society of Genetic Counselors, Inc
Novartis Oncology
Oncology Nursing Society
Partners In Health
Pfizer Inc.
Regeneron Pharmaceuticals
The Jackson Laboratory (JAX)
University of California, San Francisco
University of Vermont Health Network Medical Group
Staff
Kathryn Asalone
Michelle Drewry
Ashley Pitt
Jennifer Zhu
